EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages -10.32% over 3 years and -3.20% over 5 years; the trailing 12 months came in at +13.16%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
BIO EBITDA CAGR Chart
Bio-Rad Laboratories, Inc. (BIO)
tgmcharts.com
BIO Quarterly EBITDA Growth (YoY)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
tgmcharts.com
EBITDA
BIO Quarterly EBITDA
$72.60M
Reported quarterly EBITDA; no daily interpolation.